# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday.
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company ...
Citigroup analyst Alexandra Davis maintains BRC (NYSE:BRCC) with a Neutral and raises the price target from $3.5 to $4.75.
Telsey Advisory Group analyst Sarang Vora reiterates BRC (NYSE:BRCC) with a Outperform and maintains $8 price target.
Telsey Advisory Group analyst Sarang Vora reiterates BRC (NYSE:BRCC) with a Outperform and maintains $8 price target.
The company expects continued acceleration of profit and cash flow in 2024 with guidance issued for Adjusted EBITDA of $27.0 mi...
BRC (NYSE:BRCC) reported quarterly losses of $(0.070) per share. This is a 22.22 percent increase over losses of $(0.090) per s...